Financial figures

Overview of DSM's latest financial key figures

Key financials

Presented below are DSM's net salesbalance sheet, income statement and cash flow statement as at H1 2022*.

* From Q1 2021 onwards, in line with the established practice of many of DSM's consumer ingredients peers, we provide trading updates for Q1 and Q3 reporting sales, organic growth, Adjusted EBITDA and Adjusted EBITDA margins.

We report full financial details for half year and full year results and host calls for the media and analysts for both.

Net sales

in € million

Year Q1 Q2 Q3 Q4 Total
2022 2,008¹ 2,107¹ 2,182¹    
2021 1,727¹ 1,790¹ 1,825¹ 1,928¹ 7,269¹
2020 2,045² 2,020² 1,961² 2,080² 8,106²
2019 2,021² 2,008² 2,035² 1,934² 7,998²
2018 2,435 2,359 2,265 2,208 9,267
2017 2,159 2,161 2,136 2,176 8,632
2016 1,913 1,994 1,998 2,015 7,920
2015 1,886 1,754 2,102 1,926 7,722
2014 2,298 2,288 2,323 2,175 9,181
2013 2,376 2,468 2,397 2,377 9,618
2012 2,290 2,268 2,304 2,269 9,131
2011 2,234 2,265 2,322 2,227 9,048
2010 1,933 2,120 2,041 2,082 8,176
2009 1,578 1,664 1,725 1,758 6,725
2008 2,303 2,406 2,336 2,034 9,079

¹ Figures reflect continuing operations which include DSM’s Health, Nutrition & Bioscience and Corporate Activities. In May 31, 2022 DSM announced the sale of DSM Protective Materials and DSM Engineering Materials. All of DSM’s Materials businesses were reclassified to discontinued operations.

²  Figures reflect the reclassification of the DSM’s Resins & Functional Materials businesses to discontinued operations. The sale with an equity value of €1.6 billion was subsequently finalized on 01 April 2021.

Balance sheet H1 2022

Assets in € million 30 June 2022 Year-end 2021
Intangible Assets 5,192 5,309
Property, Plant & Equipment 3,570 3,964
Deferred Tax Assets 133 203
Prepaid pension cost 35 75
Share in Associates & Joint Ventures 63 64
Financial derivatives 78 48
Other Financial Assets 203 227
Non-Current Assets 9,274 9,890
Inventories 2,394 2,297
Trade Receivables 1,679 1,604
Income tax receivables 55 61
Other Current Receivables 40 32
Derivatives 55 30
Current Investments 838 489
Cash & Cash Equivalents 792 1,561
Sub-total 5,853 6,074
Assets Held for Sale 1,726 56
Current Assets 7,579 6,130
Total Assets 16,853 16,020
Shareholders' Equity 9,731 9,318
Non-controlling interest 92 79
Equity 9,823 9,397
Deferred Tax Liabilities 491 490
Employee Benefits Liabilities 241 323
Provisions 87 96
Borrowings 2,985 2,995
Derivatives 17 9
Other Non-current Liabilities 189 280
Non-current liabilities 4,010 4,193
Employee Benefits 20 21
Provisions 67 68
Borrowings 98 103
Derivatives 58 40
Trade Payables 1,541 1,571
Income tax payable 97 77
Other Current Liabilities 611 540
Sub-total 2,492 2,420
Liabilities associated with the assets held for sale 528 10
Current Liabilities 3,020 2,430
Total Equity and Liabilities 16,853 16,020
Net debt 1,395 1,019
Equity/Total Assets  58% 59%

Income statement H1 2022

Continuing operations in € million H1 2022 H1 2021
Sales 4,115 3,517
Gross margin 1,426 1,265
Operating profit (EBIT) 398 394
Financial income and expense -39 -65
Profit before income tax expense 359 329
Income tax expense -72 -64
Share of the profit of associates/
joint control entities
4 20
Net profit from continuing operations 291 285
Of which:    
Attributable to non-controlling interests 8 2
Dividend on cumulative preference shares 1 4
Available to holders of ordinary shares 449 1,004
Condensed Consolidated Statement of Comprehensive Income in € million H1 2022 H1 2022
Net profit for the period 458 1,010
Other comprehensive income    
Remeasurements of Defined Benefit Pension Plans 31 199
Change in Fair Value Reserve -31 208
FX on Translation of Foreign Operations Related to Non-Controlling Interest 4 3
Items that will not be reclassified to profit or loss 4 410
FX on Translation of Foreign Operations 489 152
Change in Hedging Reserve 8 -12
Equity accounted investees - share of Other comprehensive income   2
Items that may subsequently be reclassified to profit or loss 497 142
Other Comprehensive Income (before tax) 501 552
Income Tax Expense -15 -22
Other Comprehensive Income (net of tax) 486 530
Total Comprehensive Income 944 1,540

Cash flow statement H1 2022

in € million H1 2022 H1 2021
 Cash, Cash Equivalents and Current Investments (at beginning of period)  1,561 871
 Operating Activities     
 EBITDA  933 1,548
 Change in Working  Capital  -596 -260
 Income Tax   -72 -51
 Other  34 -658
 Cash provided by Operating Activities (Operating cash flow)   299 579
 of which provided by continuing operations   216 372
 Investing Activities     
 Capital Expenditures   -299 -236
 Payments regarding drawing rights  -2 -5
 Acquisitions     -212
 Disposal of Subsidiaries, Businesses & Associates  -6 1462
 Disposal of Other Non-current Assets  24 131
 Change in Fixed-term Deposits  -348 -172
 Interest Received  1 3
 Dividend and capital (re)payments   -16 -19
 Other  -16 18
 Cash used in Investing Activities  -662 970
 Financing Activities     
 Dividend  -156 -170
 Interest Paid   -34 -46
 Repurchase of shares  -210 -120
 Proceeds from re-issued treasury shares  14 18
 Change in Commercial Paper    0
 Proceeds from / repayments of corporate bonds  0 -500
 Payment of lease liabilities  -29 -27
 Other Cash from/ used in Financing Activities   -6 74
 Cash from / used in Financing Activities -421 -771
 Exchange Differences  15 -9
 Cash and Cash Equivalents (end of period)  792 1,640

Read more